UBS Price Target Changes for 10/24/2011
Tags: UBS Investment Research
Posted in: Price Target, Analyst Ratings
UBS has changed price targets today on the following companies:
Abbott Laboratories (NYSE: ABT) Buy, PT raised from $59 to $60
Omnicare (NYSE: OCR) Neutral, PT lowered from $31 to $29
Owens & Minor (NYSE: OMI) Neutral, PT Lowered from $32 to $31
Schlumberger (NYSE: SLB) Buy, PT lowered from $100 to $95
Taubman Centers (NYSE: TCO) Buy, PT raised from $60 to $61
(c) 2012 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
We're Loving
